PRNewsWire
04 Feb 2026, 22:48 UTC · 37w ago
VTGN CLASS ACTION ALERT: Robbins LLP Urges Vistagen Therapeutics, Inc. Stockholders to Reach Out for Information About the Securities Class Action Lawsuit
Impact · against what's priced in
The news is overwhelmingly negative for VTGN following a catastrophic Phase 3 trial failure and subsequent class action lawsuit. For REGN and SION, the news is less material as it pertains to initial legal investigations by a law firm.
- VTGN−1.00
No priced-in read yet





